Download PDF
Frauenheilkunde up2date 2014; 8(5): 327-338
DOI: 10.1055/s-0033-1358001
Gynäkologische Endokrinologie und Reproduktionsmedizin
Georg Thieme Verlag KG Stuttgart · New York

Hormontherapie im Klimakterium

Claus Lattrich
,
Olaf Ortmann
Further Information

Publication History

Publication Date:
28 October 2014 (online)

Also available at
    Permissions and Reprints All articles of this category
Kernaussagen

Die Hormontherapie (HT) in der Peri- und Postmenopause ist eine häufig indizierte Pharmakotherapie. Die HT sollte nur bei einer eindeutigen Indikation im Sinne der vorliegenden Leitlinienempfehlungen eingesetzt werden. Bei Beginn und im Intervall sollte mit der Patientin eine Nutzen-Risiken-Analyse der HT durchgeführt werden. Für die meisten Frauen ist die kurzzeitige Behandlung der vasomotorischen Beschwerden oder der Vaginalatrophie mit Östrogenen eine gute Option. Längerfristige Therapien können jedoch bei behandlungsbedürftigen Symptomen erforderlich sein. Verschiedene Präparate und Applikationsformen stehen zur Verfügung. Eine weitere Krankheitsprävention ist mit Östrogenen als First-Line-Therapie nicht möglich oder empfehlenswert.

 

  • Literatur

  • 1 New Zealand Guidelines Group. The appropriate prescribing of hormone replacement therapy. Best practice evidence-based guideline. Manatū Hauora, Māori, Neuseeland: New Zealand Guidelines Group; 2001
    Google Scholar
  • 2 Arzneimittelkommission der Deutschen Ärzteschaft. Hormontherapie im Klimakterium. http://www.akdae.de/Arzneimitteltherapie/TE/A-Z/PDF/Hormontherapie.pdf
    Google Scholar
  • 3 Maclennan AH, Broadbent JL, Lester S et al. Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev 2004; (4) CD002978
    Google Scholar
  • 4 North American Menopause Society. Estrogen and progestogen use in peri- and postmenopausal women: March 2007 position statement of The North American Menopause Society. Menopause 2007; 14: 168-182
    CrossrefGoogle Scholar
  • 5 Vesco KK, Haney EM, Humphrey L et al. Influence of menopause on mood: a systematic review of cohort studies. Climacteric 2007; 10: 448-465
    CrossrefGoogle Scholar
  • 6 Eberhardt S, Kulp W, von der Schulenburg JM et al. Hormones for therapy of climacteric afflictions. GMS health technology assessment 2007; 3: Doc03
    Google Scholar
  • 7 Utian WH, Archer DF, Bachmann GA et al. Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society. Menopause 2008; 15: 584-602
    CrossrefGoogle Scholar
  • 8 Perrotta C, Aznar M, Mejia R et al. Oestrogens for preventing recurrent urinary tract infection in postmenopausal women. Cochrane Database Syst Rev 2008; (2) CD005131
    Google Scholar
  • 9 Deutsche Gesellschaft für Gynäkologie und Geburtshilfe. S3-Leitlinie „Hormontherapie in der Peri- und Postmenopause“. http://www.awmf.org/leitlinien/detail/ll/015-062.html
    Google Scholar
  • 10 LaCroix AZ, Chlebowski RT, Manson JE et al. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. J Am Med Assoc 2011; 305: 1305-1314
    CrossrefGoogle Scholar
  • 11 Anderson GL, Chlebowski RT, Aragaki AK et al. Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Womenʼs Health Initiative randomised placebo-controlled trial. Lancet Oncol 2012; 13: 476-486
    CrossrefGoogle Scholar
  • 12 Moehrer B, Hextall A, Jackson S. Oestrogens for urinary incontinence in women. Cochrane Database Syst Rev 2003; (2) CD001405
    Google Scholar
  • 13 Grady D, Brown JS, Vittinghoff E et al. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001; 97: 116-120
    CrossrefGoogle Scholar
  • 14 Barnabei VM, Cochrane BB, Aragaki AK et al. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Womenʼs Health Initiative. Obstet Gynecol 2005; 105: 1063-1073
    CrossrefGoogle Scholar
  • 15 Ortmann O. Hormontherapie in der Peri- und Postmenopause. Frauenarzt 2009; 50: 840-851
    Google Scholar
  • 16 The North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010; 17: 242-255
    CrossrefGoogle Scholar
  • 17 Dannecker C, Friese K, Stief C et al. Urinary incontinence in women: part 1 of a series of articles on incontinence. Dtsch Arzteblatt Int 2010; 107: 420-426
    Google Scholar
  • 18 Ortmann O, Dören M, Windler E. Hormone therapy in perimenopause and postmenopause (HT): Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version. Arch Gynecol Obstet 2011; 284: 343-355
    CrossrefGoogle Scholar
  • 19 Deutsche Gesellschaft für Osteologie e.V. (DGO). S3 Leitlinie „Prophylaxe, Diagnostik und Therapie der Osteoporose bei Frauen ab der Menopause, bei Männern ab dem 60. Lebensjahr“. http://www.awmf.org/uploads/tx_szleitlinien/034-003_S3_Prophylaxe__Diagnostik_und_Therapie_der_Osteoporose_bei_Erwachsenen_lang_10-2009_12-2012.pdf
    Google Scholar
  • 20 Torgerson DJ, Bell-Syer SE. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. J Am Med Assoc 2001; 285: 2891-2897
    CrossrefGoogle Scholar
  • 21 Wells G, Tugwell P, Shea B et al. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr Rev 2002; 23: 529-539
    CrossrefGoogle Scholar
  • 22 Farquhar CM, Marjoribanks J, Lethaby A et al. Long term hormone therapy for perimenopausal and postmenopausal women. Cochrane Database Syst Rev 2005; (3) CD004143
    Google Scholar
  • 23 MacLean C, Newberry S, Maglione M et al. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann Intern Med 2008; 148: 197-213
    CrossrefGoogle Scholar
  • 24 Beral V, Reeves G, Bull D et al. Breast cancer risk in relation to the interval between menopause and starting hormone therapy. J Natl Cancer Inst 2011; 103: 296-305
    CrossrefGoogle Scholar
  • 25 The North American Menopause Society. The 2012 hormone therapy position statement of The North American Menopause Society. Menopause 2012; 19: 257-271
    Google Scholar
  • 26 Zhou B, Sun Q, Cong R et al. Hormone replacement therapy and ovarian cancer risk: a meta-analysis. Gynecol Oncol 2008; 108: 641-651
    CrossrefGoogle Scholar
  • 27 Morch LS, Lokkegaard E, Andreasen AH et al. Hormone therapy and ovarian cancer. J Am Med Assoc 2009; 302: 298-305
    CrossrefGoogle Scholar
  • 28 Grodstein F, Newcomb PA, Stampfer MJ. Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med 1999; 106: 574-582
    CrossrefGoogle Scholar
  • 29 Tsilidis KK, Allen NE, Key TJ et al. Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2011; 128: 1881-1889
    CrossrefGoogle Scholar
  • 30 Freeman EW, Sammel MD, Lin H et al. Duration of menopausal hot flushes and associated risk factors. Obstet Gynecol 2011; 117: 1095-1104
    CrossrefGoogle Scholar
  • 31 Grady D, Gebretsadik T, Kerlikowske K et al. Hormone replacement therapy and endometrial cancer risk: a meta-analysis. Obstet Gynecol 1995; 85: 304-313
    CrossrefGoogle Scholar
  • 32 World Health Organization. Combined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy. IARC monographs on the evaluation of carcinogenic risks to humans/World Health Organization, International Agency for Research on Cancer 2007; 91: 1-528
    Google Scholar
  • 33 Nelson HD, Vesco KK, Haney E et al. Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. J Am Med Assoc 2006; 295: 2057-2071
    CrossrefGoogle Scholar
  • 34 The North American Menopause Society. Menopause Practice: A Clinicianʼs Guide. 4th ed. Mayfield Heights, OH, USA: The North American Menopause Society; 2010
    Google Scholar